Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Seifert

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scientific Reports|August 13, 2020
Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H<sub>3</sub> receptor for Prader-Willi SyndromeDavid Reiner, Ludwig Seifert, Caroline Deck, et al.
International Journal of Molecular Sciences|June 2, 2021
Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 InhibitorsChiara Luise, Dina Robaa, Pierre Regenass, et al.
Journal of Medicinal Chemistry|March 27, 2024
Discovery of a Potent, Selective, and Cell-Active SPIN1 InhibitorYan Xiong, Holger Greschik, Catrine Johansson, et al.
Journal of Medicinal Chemistry|July 2, 2019
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1)Yan Xiong, Holger Greschik, Catrine Johansson, et al.
Journal of Medicinal Chemistry|May 5, 2026
Development of High-Affinity CHD1 Chromodomain InhibitorsHolger Greschik, Florian Friedrich, Ludwig Seifert, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scientific Reports|August 13, 2020
Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H<sub>3</sub> receptor for Prader-Willi SyndromeDavid Reiner, Ludwig Seifert, Caroline Deck, et al.
International Journal of Molecular Sciences|June 2, 2021
Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 InhibitorsChiara Luise, Dina Robaa, Pierre Regenass, et al.
Journal of Medicinal Chemistry|March 27, 2024
Discovery of a Potent, Selective, and Cell-Active SPIN1 InhibitorYan Xiong, Holger Greschik, Catrine Johansson, et al.
Journal of Medicinal Chemistry|July 2, 2019
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1)Yan Xiong, Holger Greschik, Catrine Johansson, et al.
Journal of Medicinal Chemistry|May 5, 2026
Development of High-Affinity CHD1 Chromodomain InhibitorsHolger Greschik, Florian Friedrich, Ludwig Seifert, et al.
Pageof 1